R&D Introduction
R&D OVERVIEW
Development Leading Innovation
Laboratory
Korea's No. 1
API Research Institute
A leading API company Recognized
At Home
And Abroad
Daewoong Bio’s lab demonstrates
global healthcare impact through
recognized research and
innovative technologies.
Our achievements
Research Center
Overview
Daewoong Bio’s research lab, Korea’s No.1
API facility,
is recognized globally for its
quality. We provide high-purity UDCA
and
One-Stop Services—from API synthesis to
clinical and CMC
research—meeting diverse
customer needs.
Core Health Tech
Daewoong Bio leads the development of
global diabetes drug APIs with
eco-friendly,
high-yield production using enzyme
synthesis and
redox reactions.
Safe and efficient Flow Systems ensure
reliable production,
while virus inactivation,
process optimization, and scale-up secure
stable
commercial manufacturing.
Key Portfolio
UDCA, a high-purity natural API, achieves
high yields through eco-friendly
enzyme
processes and is exported to over 29
countries, including France,
Germany, and
Japan. Enavogliflozin has a Flow System-
based synthesis
process with completed PV.
DCA ensures stable supply via enzyme
synthesis
and virus-inactivated animal-
source production, with PV completed.
Our achievements
Research Center
Overview
Daewoong Bio’s research lab, Korea’s No.1
API facility,
is recognized globally for its
quality. We provide high-purity UDCA
and
One-Stop Services—from API synthesis to
clinical and CMC
research—meeting diverse
customer needs.
Core Health Tech
Daewoong Bio leads the development of
global diabetes drug APIs with
eco-friendly,
high-yield production using enzyme
synthesis and
redox reactions.
Safe and efficient Flow Systems ensure
reliable production,
while virus inactivation,
process optimization, and scale-up secure
stable
commercial manufacturing.
Key Portfolio
UDCA, a high-purity natural API, achieves
high yields through eco-friendly
enzyme
processes and is exported to over 29
countries, including France,
Germany, and
Japan. Enavogliflozin has a Flow System-
based synthesis
process with completed PV.
DCA ensures stable supply via enzyme
synthesis
and virus-inactivated animal-
source production, with PV completed.